|
SOCS7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.38109556913469E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.74225087082414E-14 |
| Normal-vs-Stage2 |
1.42489999999107E-06 |
| Normal-vs-Stage3 |
7.93443089008861E-12 |
| Normal-vs-Stage4 |
3.35287353436797E-12 |
| Stage1-vs-Stage2 |
4.209800E-01 |
| Stage1-vs-Stage3 |
1.092800E-01 |
| Stage1-vs-Stage4 |
2.687800E-02 |
| Stage2-vs-Stage3 |
5.791800E-02 |
| Stage2-vs-Stage4 |
3.120300E-02 |
| Stage3-vs-Stage4 |
5.287400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.73699976413877E-11 |
| Normal-vs-AfricanAmerican |
2.90859999974025E-07 |
| Normal-vs-Asian |
6.86820000872501E-09 |
| Caucasian-vs-AfricanAmerican |
7.939200E-01 |
| Caucasian-vs-Asian |
9.312800E-01 |
| AfricanAmerican-vs-Asian |
7.632400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3964163986534E-12 |
| Normal-vs-Female |
1.62736490949555E-12 |
| Male-vs-Female |
2.351900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.39885888930758E-12 |
| Normal-vs-Age(41-60Yrs) |
2.60902410786912E-14 |
| Normal-vs-Age(61-80Yrs) |
2.51689780128572E-11 |
| Normal-vs-Age(81-100Yrs) |
5.159700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.656000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.740180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.175800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.686800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.755600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.431600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.30579999999292E-06 |
| Classical-VS-Follicular |
6.427600E-01 |
| Classical-VS-Other |
1.741040E-01 |
| Classical-VS-Normal |
1.10870002067998E-09 |
| Tall-VS-Follicular |
1.981020E-03 |
| Tall-VS-Other |
9.499600E-01 |
| Tall-VS-Normal |
3.09752223870419E-14 |
| Follicular-VS-Other |
2.581800E-01 |
| Follicular-VS-Normal |
2.25359952921167E-10 |
| Other-VS-Normal |
2.991100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.60822483003176E-14 |
| Normal-vs-N1 |
6.63480048679332E-10 |
| N0-vs-N1 |
3.069200E-01 |
|
|
